✨
Yapay Zeka Hızlı Bakış & Çıkarımlar
AI Insight⚡ TL;DR(1 Cümlede Hızlı Çıkarım)
In conclusion, we recommend levetiracetam as the first line treatment for EPC, which is mostly refractory to classical antiepileptic drugs
📌 3 Maddede Bu Makale
🎯
Amaç & Hipotez:An 82-year-old, right-handed male patient was admitted to the emergency room because of continuous rhythmic clonic movements of the right forearm and hand.
📊
Temel Bulgular & Veri:He was diagnosed with epilepsia partialis continua (EPC) and treated successfully with levetiracetam.
💡
Sonuç & Katkı:In conclusion, we recommend levetiracetam as the first line treatment for EPC, which is mostly refractory to classical antiepileptic drugs
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri
Abstract
An 82-year-old, right-handed male patient was admitted to the emergency room because of continuous rhythmic clonic movements of the right forearm and hand. He was diagnosed with epilepsia partialis continua (EPC) and treated successfully with levetiracetam. In conclusion, we recommend levetiracetam as the first line treatment for EPC, which is mostly refractory to classical antiepileptic drugs
🔖
Bu Makaleye Atıf Yap
YÖN, M. İ., ULUSOY, E. K., BİLEN, Ş., YÖN, M. E. E. (2016). Levetiracetam May be the First Choice for Managing Epilepsia Partialis Continua Related to Ischemic Stroke. Erciyes Medical Journal, Cilt: 38 - Sayı: 4, 157–158. https://ajindex.com/articles/203580